https://www.selleckchem.com/pr....oducts/GDC-0980-RG74
trials, PA pressure-guided therapy for HF was associated with lower PA pressures, lower rates of HFH and all-cause hospitalization, and low rates of adverse events across a broad range of patients with symptomatic HF and prior HFH. Registration URL https//www.clinicaltrials.gov. Unique identifier NCT02279888. In routine clinical practice as in clinical trials, PA pressure-guided therapy for HF was associated with lower PA pressures, lower rates of HFH and all-cause hospitalization, and low rates of adverse events across a broad
Beğen
Yorum Yap
Paylaş
